Hub : Traits :

Hayfever, allergic rhinitis or eczema

999 significantly associated models · 238 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	2235672	2742491	2	1	2.0e-09	4.1e-13	6.0e-06	61	TNFRSF14
2	1	7686056	9637591	4	1	1.2e-12	8.0e-12	1.0e+00	100	RP5-1115A15.1
3	1	24372971	25768937	1	1	1.7e-07	5.2e-12	1.3e-07	41	CLIC4
4	1	151313774	152712747	4	8	7.4e-20	1.8e-19	0.0e+00	-4170	LINGO4 S100A11 TDRKH THEM4
5	1	153225886	155138557	3	2	9.3e-12	5.8e-14	9.7e-04	81	C1orf43 IL6R
6	1	160452218	161885352	4	1	2.5e-09	1.4e-09	1.6e-01	94	PPOX
7	1	166702558	168182443	1	1	2.4e-17	1.6e-18	1.0e+00	100	CD247
8	1	172311679	173713130	2	1	2.5e-13	3.7e-13	1.0e+00	100	TNFSF4
9	2	27971195	29344127	1	1	2.0e-13	2.2e-09	2.5e-01	96	RP11-373D23.3
10	2	29976100	31563885	1	1	9.6e-08	5.1e-07	9.3e-01	100	LCLAT1
11	2	60466491	62123953	9	1	6.4e-10	4.7e-08	2.8e-02	84	AC010733.5
12	2	101994731	103767612	5	4	4.4e-61	1.7e-54	1.0e+00	100	IL18RAP IL1RL1 IL1RL2
13	2	143154021	145209076	1	1	2.6e-08	9.9e-12	3.7e-05	63	ARHGAP15
14	2	197134790	200117777	6	1	1.7e-15	1.4e-14	2.0e-03	84	SF3B1
15	2	228433917	229037885	2	1	4.4e-12	4.2e-11	6.1e-02	92	CCL20
16	2	241978472	243048760	7	2	1.2e-19	1.8e-20	3.0e-01	99	AC114730.7 D2HGDH
17	3	120799666	122356172	4	1	2.5e-12	2.2e-12	1.0e+00	100	SLC15A2
18	3	140350567	141867638	1	1	3.0e-09	9.8e-10	1.0e+00	100	ZBTB38
19	3	195746112	197161849	1	1	4.1e-08	3.3e-06	1.1e-04	31	PIGX
20	4	38079294	39824758	5	2	1.1e-67	5.6e-73	2.9e-05	95	TLR1 TLR6
21	4	102736456	104627833	3	1	6.4e-11	9.5e-10	7.6e-01	100	NFKB1
22	4	122377715	124935698	2	5	1.7e-35	9.6e-30	1.5e-01	98	KIAA1109 SPATA5
23	5	34920257	36848558	5	10	1.1e-41	4.5e-45	1.0e+00	100	CAPSL IL7R LMBRD2 SPEF2 UGT3A2
24	5	108927715	111770880	6	10	4.4e-42	8.7e-55	NaN	NaN	CAMK4 SLC25A46 TSLP WDR36
25	5	130830617	132900729	13	3	2.5e-10	6.3e-11	5.9e-01	99	IRF1 KIF3A SLC22A5
26	5	140298815	142230251	2	2	7.0e-09	1.1e-07	4.7e-01	98	AC008781.7 NDFIP1
27	5	176539212	177047009	1	1	3.7e-08	1.9e-07	3.5e-01	97	RGS14
28	6	25266147	26689223	3	1	6.9e-13	1.2e-12	5.3e-02	93	U91328.19
29	6	33745071	35200350	1	1	1.8e-07	7.8e-09	5.1e-08	11	PACSIN1
30	6	89941356	91704536	1	1	8.3e-12	1.3e-12	5.2e-03	84	BACH2
31	6	134905567	136516257	2	1	5.3e-10	2.5e-10	3.3e-02	89	AHI1
32	7	27623776	28468319	1	2	4.7e-10	2.2e-17	8.7e-06	72	JAZF1
33	7	76254810	77744459	1	1	1.7e-07	1.1e-09	1.1e-03	71	GSAP
34	7	140009905	141413051	1	1	5.4e-08	1.3e-06	9.6e-01	100	MRPS33
35	9	5091675	7345304	3	2	8.4e-17	2.7e-18	7.1e-09	56	GLDC RANBP6
36	9	122881960	124487495	6	1	5.2e-14	9.1e-14	1.0e+00	100	TRAF1
37	9	126321003	127872298	2	1	7.4e-10	1.1e-09	1.0e+00	100	NEK6
38	10	5238196	6801162	2	2	5.9e-11	5.1e-23	1.2e-15	34	IL2RA
39	10	103527782	105647095	10	1	1.7e-13	1.0e-11	4.0e-01	98	WBP1L
40	11	36068766	36732916	1	1	2.5e-10	5.7e-07	8.8e-03	73	PRR5L
41	11	64669105	66456387	12	2	7.5e-13	3.3e-17	3.2e-04	82	EFEMP2 OVOL1
42	11	75453877	77069746	3	1	6.2e-36	4.8e-57	2.0e-25	57	LRRC32
43	11	110721187	112335631	3	1	3.8e-13	2.3e-14	1.0e+00	100	SIK2
44	12	50110317	50601155	1	1	6.2e-09	7.7e-08	1.8e-01	94	AQP5
45	12	55677395	58222672	10	3	2.6e-19	1.3e-21	1.8e-01	98	GPR182 STAT6 SUOX
46	12	111645043	113036817	1	1	1.0e-07	1.3e-15	1.5e-10	36	ADAM1A
47	12	120502726	122873570	2	1	3.1e-10	3.1e-10	1.0e+00	100	SPPL3
48	12	122942185	124424636	2	2	2.5e-08	2.3e-07	4.8e-01	98	MLXIP MPHOSPH9
49	13	40440805	41928314	2	1	3.3e-17	4.8e-13	6.6e-03	86	FOXO1
50	13	72661114	74288499	1	1	4.1e-09	4.0e-11	2.3e-05	59	PIBF1
51	13	99603738	100287551	1	1	1.6e-08	5.1e-08	7.9e-03	76	UBAC2
52	14	34820295	36440325	3	1	1.3e-11	1.2e-10	7.4e-02	92	FAM177A1
53	14	102544860	104074810	1	1	1.6e-09	2.8e-11	1.3e-07	37	TRAF3
54	15	40778506	42749023	9	1	3.0e-11	1.6e-12	1.1e-03	79	NDUFAF1
55	15	66662107	68183665	1	1	1.3e-16	2.6e-21	3.7e-06	76	SMAD3
56	15	89921477	91886448	4	2	1.1e-22	1.1e-19	4.1e-03	90	IQGAP1 ZNF774
57	16	10325245	12138068	6	7	2.6e-27	1.2e-34	NaN	NaN	CLEC16A DEXI RMI2 RP11-396B14.2 RP11-876N24.5
58	17	36710513	39502398	19	9	1.3e-23	7.1e-22	1.0e+00	100	CASC3 GSDMA MED24 MSL1 ORMDL3 SMARCE1 THRA
59	17	39993748	41538783	7	1	9.7e-11	2.4e-08	4.1e-01	98	NAGLU
60	17	42628193	43570226	3	1	1.5e-08	1.3e-09	1.0e+00	100	C17orf46
61	17	47119135	47685050	1	1	1.0e-08	1.1e-09	3.1e-02	88	ZNF652
62	18	51100222	52540420	1	1	7.7e-08	7.7e-08	1.0e+00	100	POLI
63	20	51935779	52456445	1	1	8.4e-11	1.0e-15	6.3e-09	48	ZNF217
64	20	61522825	62912463	7	1	7.2e-10	8.2e-10	1.0e-01	93	STMN3
65	22	21075537	22685340	4	1	2.8e-09	2.7e-09	1.0e+00	100	CCDC116
66	22	41606030	42109917	1	1	1.8e-07	7.4e-07	2.8e-01	95	PHF5A

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Allergy or Eczema	28.30	100	98	217.8	1.00	5.9e-136	AC008781.7 AC010733.5 AC114730.7 ADAM1A AHI1 AQP5 ARHGAP15 BACH2 C17orf46 C1orf43 CAMK4 CAPSL CASC3 CCDC116 CCL20 CD247 CLEC16A CLIC4 D2HGDH DEXI EFEMP2 FAM177A1 FOXO1 GLDC GPR182 GSAP GSDMA IL18RAP IL1RL1 IL1RL2 IL2RA IL6R IL7R IQGAP1 IRF1 JAZF1 KIAA1109 KIF3A LCLAT1 LINGO4 LMBRD2 LRRC32 MED24 MLXIP MPHOSPH9 MRPS33 MSL1 NAGLU NDFIP1 NDUFAF1 NEK6 NFKB1 ORMDL3 OVOL1 PACSIN1 PHF5A PIBF1 PIGX POLI PPOX PRR5L RANBP6 RGS14 RMI2 RP11-373D23.3 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 S100A11 SF3B1 SIK2 SLC15A2 SLC22A5 SLC25A46 SMAD3 SMARCE1 SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUOX TDRKH THEM4 THRA TLR1 TLR6 TNFRSF14 TNFSF4 TRAF1 TRAF3 TSLP UBAC2 UGT3A2 WBP1L WDR36 ZBTB38 ZNF217 ZNF652 ZNF774
Allergy	27.15	98	88	195.6	-0.99	4.0e-106	AC008781.7 AC010733.5 AC114730.7 ADAM1A AHI1 AQP5 ARHGAP15 BACH2 C17orf46 C1orf43 CAMK4 CAPSL CASC3 CCDC116 CCL20 CD247 CLEC16A CLIC4 D2HGDH DEXI EFEMP2 FAM177A1 FOXO1 GLDC GPR182 GSAP GSDMA IL18RAP IL1RL1 IL1RL2 IL2RA IL6R IL7R IQGAP1 IRF1 JAZF1 KIAA1109 KIF3A LCLAT1 LINGO4 LMBRD2 LRRC32 MED24 MLXIP MPHOSPH9 MRPS33 MSL1 NAGLU NDFIP1 NDUFAF1 NEK6 NFKB1 ORMDL3 OVOL1 PACSIN1 PHF5A PIGX POLI PPOX PRR5L RANBP6 RGS14 RMI2 RP11-373D23.3 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 S100A11 SF3B1 SIK2 SLC15A2 SLC22A5 SLC25A46 SMAD3 SMARCE1 SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUOX THEM4 THRA TLR1 TLR6 TNFRSF14 TNFSF4 TRAF1 TRAF3 TSLP U91328.19 UBAC2 UGT3A2 WBP1L WDR36 ZBTB38 ZNF217 ZNF652
Asthma	18.17	55	45	100.0	0.95	4.5e-38	AC114730.7 AHI1 BACH2 CAMK4 CASC3 CCL20 CD247 D2HGDH DEXI EFEMP2 GLDC GPR182 GSDMA IL18RAP IL1RL1 IL1RL2 IL7R IRF1 JAZF1 KIAA1109 KIF3A LINGO4 LRRC32 MED24 MSL1 NAGLU NDFIP1 NDUFAF1 ORMDL3 PHF5A POLI PPOX RANBP6 RGS14 RMI2 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 S100A11 SIK2 SLC22A5 SLC25A46 SMAD3 SMARCE1 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TNFSF4 TSLP UBAC2 WDR36 ZNF652
Asthma (self-reported)	17.97	57	45	100.0	0.95	3.7e-38	AC114730.7 AHI1 BACH2 CAMK4 CASC3 CCL20 CD247 D2HGDH DEXI EFEMP2 GLDC GPR182 GSDMA IL18RAP IL1RL1 IL1RL2 IL7R IRF1 JAZF1 KIAA1109 KIF3A LINGO4 LRRC32 MED24 MSL1 NAGLU NDFIP1 NDUFAF1 ORMDL3 OVOL1 PHF5A POLI PPOX RANBP6 RGS14 RMI2 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 S100A11 SIK2 SLC22A5 SLC25A46 SMAD3 SMARCE1 SPATA5 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TNFSF4 TSLP UBAC2 WDR36 ZNF652
Respiratory disease	17.89	66	44	97.8	0.94	5.2e-41	AC008781.7 AC114730.7 AHI1 BACH2 C17orf46 C1orf43 CAMK4 CASC3 CCL20 CD247 D2HGDH DEXI EFEMP2 FOXO1 GLDC GPR182 GSDMA IL18RAP IL1RL1 IL1RL2 IL2RA IL6R IL7R IRF1 JAZF1 KIAA1109 KIF3A LINGO4 LRRC32 MED24 MPHOSPH9 MSL1 NAGLU NDFIP1 NDUFAF1 ORMDL3 PHF5A POLI PPOX RANBP6 RGS14 RMI2 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 S100A11 SIK2 SLC15A2 SLC22A5 SLC25A46 SMAD3 SMARCE1 SPATA5 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TNFSF4 TRAF1 TSLP UBAC2 WDR36 ZNF217 ZNF652
Blood Eosinophil Count	15.16	67	57	126.7	0.85	5.0e-24	AC114730.7 ADAM1A AHI1 BACH2 CAMK4 CAPSL CASC3 CCDC116 CD247 CLIC4 D2HGDH DEXI EFEMP2 FAM177A1 FOXO1 GLDC GPR182 GSDMA IL18RAP IL1RL1 IL1RL2 IL2RA IL7R IRF1 KIAA1109 KIF3A LCLAT1 LRRC32 MED24 MPHOSPH9 MSL1 NDFIP1 NDUFAF1 NEK6 NFKB1 ORMDL3 OVOL1 PHF5A PIBF1 POLI PPOX RANBP6 RGS14 RMI2 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 SF3B1 SIK2 SLC22A5 SLC25A46 SMAD3 SMARCE1 SPATA5 SPEF2 SPPL3 STAT6 SUOX THRA TLR6 TNFRSF14 TRAF1 TSLP UBAC2 UGT3A2 WDR36 ZNF652
Hayfever/allergic rhinitis (self-reported)	11.98	35	17	37.8	0.99	3.9e-34	AC114730.7 AHI1 BACH2 CAMK4 CD247 D2HGDH DEXI GLDC GPR182 IL18RAP IL1RL1 IL1RL2 IL7R IQGAP1 KIAA1109 LMBRD2 LRRC32 ORMDL3 PPOX RANBP6 RP11-396B14.2 RP11-876N24.5 SF3B1 SLC25A46 SMAD3 SMARCE1 SPATA5 STAT6 SUOX TLR1 TNFSF4 TSLP U91328.19 UGT3A2 WDR36
Blood White Count	9.86	38	25	55.6	0.40	9.6e-03	AC010733.5 ADAM1A AHI1 ARHGAP15 BACH2 C17orf46 CAPSL CASC3 CCDC116 DEXI EFEMP2 GSAP GSDMA IL1RL1 IQGAP1 IRF1 KIF3A MED24 MSL1 NAGLU NDFIP1 ORMDL3 PACSIN1 PIGX POLI PPOX RGS14 RP11-373D23.3 RP11-396B14.2 RP11-876N24.5 RP5-1115A15.1 SLC22A5 STMN3 THRA TRAF1 TRAF3 WBP1L ZNF217
Medication: Ventolin 100micrograms inhaler	8.15	21	9	20.0	0.95	1.8e-13	AC114730.7 BACH2 CD247 D2HGDH DEXI FOXO1 GLDC GPR182 IL18RAP IL1RL1 IL1RL2 KIAA1109 LRRC32 NDFIP1 ORMDL3 SMAD3 STAT6 SUOX THRA TLR1 ZNF652
Wheeze or whistling in the chest in last year	7.41	28	17	37.8	0.96	3.7e-19	AC114730.7 BACH2 CASC3 CD247 D2HGDH DEXI GLDC GPR182 GSDMA IL18RAP IL1RL1 IL1RL2 JAZF1 KIAA1109 LINGO4 LRRC32 MED24 MSL1 ORMDL3 RMI2 RP11-396B14.2 RP11-876N24.5 SIK2 SLC25A46 SMAD3 STMN3 THRA TSLP
Irritable Bowel Disease (IBD)	4.73	21	13	28.9	0.43	2.6e-02	AC010733.5 BACH2 CCDC116 FAM177A1 GSDMA IRF1 KIAA1109 LINGO4 LRRC32 MED24 NAGLU NDFIP1 ORMDL3 RGS14 RMI2 RP11-373D23.3 SLC22A5 SMAD3 SMARCE1 STMN3 TNFRSF14
Crohns Disease (2017)	4.62	18	14	31.1	0.40	5.6e-02	AC010733.5 CCDC116 GSDMA IRF1 KIAA1109 KIF3A LRRC32 NAGLU NDFIP1 NFKB1 ORMDL3 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3 TNFSF4 ZBTB38
Medication: Seretide 50 evohaler	4.14	7	0	0.0	0.94	5.0e-04	AC114730.7 BACH2 D2HGDH IL1RL1 SLC22A5 SMAD3 ZNF652
Number of self-reported non-cancer illnesses	3.77	11	3	6.7	0.94	2.3e-06	D2HGDH IL1RL1 IL1RL2 LINGO4 LRRC32 ORMDL3 RGS14 RP11-396B14.2 RP11-876N24.5 STMN3 ZNF652
Crohns Disease (2012)	3.66	12	6	13.3	0.38	2.0e-01	AC010733.5 CCDC116 GSDMA IRF1 LRRC32 NAGLU NDFIP1 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3
Taking other prescription medications	3.58	8	2	4.4	0.79	1.1e-02	ADAM1A D2HGDH IL1RL1 IL1RL2 MED24 MSL1 ORMDL3 ZNF652
Ulcerative Colitis (UC)	3.40	13	7	15.6	0.33	1.9e-01	AC010733.5 CCDC116 GSDMA IRF1 KIAA1109 LRRC32 MED24 ORMDL3 RGS14 SMAD3 SMARCE1 STMN3 TNFRSF14
Ulcerative Colitis	3.04	5	3	6.7	0.78	1.2e-01	AC010733.5 KIAA1109 ORMDL3 STMN3 TNFRSF14
Hypothyroidism (self reported)	3.00	16	8	17.8	0.10	7.0e-01	AC010733.5 ADAM1A AHI1 BACH2 CD247 IL7R KIAA1109 MLXIP NEK6 RP5-1115A15.1 SLC15A2 SPPL3 SUOX TLR1 TRAF1 UBAC2
Primary Biliary Cirrhosis	2.92	5	5	11.1	-0.79	1.1e-01	DEXI IL7R NFKB1 ORMDL3 RMI2
Hypothyroidism/myxoedema (self-reported)	2.79	10	4	8.9	-0.03	9.4e-01	ADAM1A AHI1 BACH2 CD247 KIAA1109 MLXIP NEK6 RP5-1115A15.1 SLC15A2 SUOX
Medication: Levothyroxine sodium	2.55	6	3	6.7	0.17	7.1e-01	ADAM1A AHI1 BACH2 IL7R SLC15A2 SUOX
Height	2.40	30	24	53.3	-0.23	2.0e-01	CCDC116 IL18RAP IL7R IQGAP1 IRF1 KIAA1109 KIF3A LMBRD2 MLXIP MPHOSPH9 MRPS33 MSL1 NDUFAF1 NFKB1 PACSIN1 PHF5A RGS14 RP11-373D23.3 RP5-1115A15.1 SLC22A5 SPEF2 SPPL3 STAT6 THRA TLR6 UGT3A2 WBP1L ZBTB38 ZNF652 ZNF774
Standing height	2.19	19	14	31.1	-0.25	3.1e-01	CCDC116 IQGAP1 IRF1 MLXIP MPHOSPH9 MSL1 NDUFAF1 PACSIN1 PHF5A RGS14 RP11-373D23.3 RP5-1115A15.1 SLC22A5 SPPL3 STAT6 WBP1L ZBTB38 ZNF652 ZNF774
Lupus	2.18	5	2	4.4	-0.23	7.1e-01	CCDC116 DEXI ORMDL3 SLC15A2 TRAF3
Arm predicted mass (left)	2.14	13	11	24.4	-0.41	1.7e-01	FOXO1 MLXIP MPHOSPH9 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Arm predicted mass (right)	2.13	12	11	24.4	-0.34	2.8e-01	MLXIP MPHOSPH9 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Arm fat-free mass (left)	2.13	13	11	24.4	-0.39	1.8e-01	FOXO1 MLXIP MPHOSPH9 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Number of treatments/medications taken	2.12	3	0	0.0	0.00	1.0e+00	ADAM1A NDUFAF1 ZNF652
Trunk predicted mass	2.11	16	11	24.4	-0.34	2.0e-01	IRF1 MLXIP MPHOSPH9 NDUFAF1 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 STAT6 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Arm fat-free mass (right)	2.11	13	10	22.2	-0.33	2.7e-01	MLXIP MPHOSPH9 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SUOX TNFRSF14 TRAF3 U91328.19 WBP1L ZBTB38
Trunk fat-free mass	2.10	17	11	24.4	-0.38	1.4e-01	IRF1 LMBRD2 MLXIP MPHOSPH9 NDUFAF1 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 STAT6 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Blood Platelet Count	2.09	30	22	48.9	0.22	2.5e-01	ADAM1A ARHGAP15 C1orf43 CASC3 CCDC116 CLIC4 FOXO1 IL6R IRF1 KIAA1109 KIF3A LCLAT1 MLXIP MPHOSPH9 NDFIP1 NEK6 ORMDL3 OVOL1 PACSIN1 PHF5A RMI2 SF3B1 SIK2 SLC15A2 SLC22A5 SPPL3 STMN3 TRAF1 TRAF3 WBP1L
Whole body fat-free mass	2.07	18	10	22.2	-0.39	1.1e-01	IRF1 JAZF1 LMBRD2 MLXIP MPHOSPH9 NDUFAF1 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 STAT6 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Lung FEV1/FVC ratio	2.05	24	13	28.9	-0.80	1.3e-06	AC010733.5 AQP5 BACH2 D2HGDH FOXO1 GLDC GSDMA IL1RL1 IL1RL2 IL7R IRF1 MED24 MSL1 ORMDL3 RGS14 RP11-396B14.2 RP5-1115A15.1 SLC22A5 SMAD3 STAT6 SUOX THRA ZBTB38 ZNF652
Whole body water mass	2.05	17	9	20.0	-0.40	1.1e-01	IRF1 JAZF1 LMBRD2 MLXIP MPHOSPH9 NEK6 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 STAT6 SUOX TRAF3 U91328.19 WBP1L ZBTB38
Basal metabolic rate	2.04	16	9	20.0	-0.45	7.8e-02	FOXO1 IRF1 JAZF1 MLXIP MPHOSPH9 PACSIN1 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 SUOX TNFRSF14 TRAF3 U91328.19 WBP1L ZBTB38
Sitting height	1.97	14	10	22.2	-0.20	5.0e-01	CCDC116 IRF1 JAZF1 KIAA1109 MLXIP MPHOSPH9 NDUFAF1 PACSIN1 RGS14 SLC22A5 STAT6 WBP1L ZBTB38 ZNF652
Leg fat-free mass (left)	1.91	15	9	20.0	-0.46	8.3e-02	FOXO1 IRF1 JAZF1 MLXIP MPHOSPH9 NAGLU PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Leg predicted mass (left)	1.91	15	9	20.0	-0.46	8.4e-02	FOXO1 IRF1 JAZF1 MLXIP MPHOSPH9 NAGLU PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Mouth/teeth dental problems: Mouth ulcers	1.91	2	0	0.0	0.00	1.0e+00	DEXI NFKB1
Weight	1.88	11	8	17.8	-0.51	1.1e-01	FOXO1 MLXIP NAGLU PACSIN1 RP11-373D23.3 SLC22A5 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Leg predicted mass (right)	1.88	14	8	17.8	-0.40	1.6e-01	IRF1 JAZF1 MLXIP MPHOSPH9 NAGLU PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Comparative height size at age 10	1.87	12	9	20.0	-0.18	5.7e-01	CCDC116 IQGAP1 IRF1 MLXIP MPHOSPH9 MSL1 PACSIN1 RP5-1115A15.1 SLC22A5 WBP1L ZBTB38 ZNF774
Leg fat-free mass (right)	1.87	14	8	17.8	-0.40	1.6e-01	IRF1 JAZF1 MLXIP MPHOSPH9 NAGLU PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Long-standing illness, disability or infirmity	1.82	1	0	0.0	0.00	1.0e+00	ZNF652
Hair/balding pattern: Pattern 4	1.81	8	4	8.9	0.25	5.5e-01	C17orf46 CLIC4 IQGAP1 POLI RP5-1115A15.1 S100A11 ZBTB38 ZNF774
Impedance of arm (right)	1.79	19	9	20.0	0.65	2.8e-03	C1orf43 GSDMA JAZF1 LCLAT1 LRRC32 MED24 NDFIP1 NEK6 ORMDL3 OVOL1 PACSIN1 PHF5A RP11-373D23.3 SF3B1 SUOX THRA TNFRSF14 U91328.19 ZNF652
Impedance of arm (left)	1.77	18	8	17.8	0.59	9.8e-03	C1orf43 DEXI GSDMA JAZF1 LCLAT1 LRRC32 MED24 NEK6 ORMDL3 OVOL1 PACSIN1 PHF5A RP11-373D23.3 SF3B1 SUOX TRAF3 U91328.19 ZNF652
Hip circumference	1.76	11	5	11.1	-0.19	5.5e-01	FOXO1 GSDMA MLXIP PACSIN1 RP11-373D23.3 STMN3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Number of operations (self-reported)	1.71	2	0	0.0	0.00	1.0e+00	DEXI NEK6
Chest pain or discomfort	1.66	3	0	0.0	0.00	1.0e+00	IL1RL1 MED24 ORMDL3
Headache pain in last month	1.64	2	1	2.2	0.00	1.0e+00	STAT6 SUOX
Diastolic blood pressure, automated reading	1.62	9	6	13.3	0.33	3.8e-01	ADAM1A CLIC4 MPHOSPH9 NDUFAF1 RP5-1115A15.1 SLC15A2 STMN3 SUOX ZNF652
Smoking Status	1.59	7	2	4.4	-0.18	7.0e-01	ADAM1A PHF5A RP5-1115A15.1 STMN3 SUOX WBP1L ZNF652
Gout (self-reported)	1.59	2	1	2.2	0.00	1.0e+00	MLXIP OVOL1
Breast Cancer	1.57	6	3	6.7	0.37	4.8e-01	EFEMP2 NAGLU OVOL1 SIK2 TLR1 ZBTB38
Prostate Cancer	1.57	2	0	0.0	0.00	1.0e+00	STMN3 WBP1L
Impedance of whole body	1.57	11	7	15.6	0.48	1.4e-01	C1orf43 DEXI JAZF1 LRRC32 NEK6 PACSIN1 PHF5A SF3B1 SUOX TNFRSF14 ZNF652
Migraine (self-reported)	1.56	1	1	2.2	0.00	1.0e+00	STAT6
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.56	2	0	0.0	0.00	1.0e+00	ORMDL3 U91328.19
Leg fat mass (right)	1.54	11	7	15.6	-0.28	4.0e-01	MLXIP NAGLU PACSIN1 RP11-373D23.3 RP5-1115A15.1 STMN3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Leg fat mass (left)	1.54	11	7	15.6	-0.29	3.8e-01	MLXIP NAGLU PACSIN1 RP11-373D23.3 RP5-1115A15.1 STMN3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Exposure to tobacco smoke outside home	1.53	1	0	0.0	0.00	1.0e+00	MED24
Vascular/heart problems diagnosed by doctor	1.53	7	5	11.1	-0.32	4.8e-01	ADAM1A NDUFAF1 RP5-1115A15.1 SIK2 SLC22A5 SUOX ZNF652
Type 2 Diabetes (T2D) (2012)	1.52	1	0	0.0	0.00	1.0e+00	JAZF1
Forced expiratory volume in 1-second (FEV1), predicted	1.52	4	2	4.4	-0.19	8.1e-01	PACSIN1 SLC22A5 WBP1L ZBTB38
Current tobacco smoking	1.50	2	1	2.2	0.00	1.0e+00	PHF5A STMN3
Trunk fat mass	1.50	10	5	11.1	-0.01	9.7e-01	MLXIP NAGLU PACSIN1 PHF5A RP5-1115A15.1 STMN3 TNFRSF14 TRAF3 U91328.19 ZBTB38
Pulse wave Arterial Stiffness index	1.50	1	1	2.2	0.00	1.0e+00	ADAM1A
Ever had prostate specific antigen (PSA) test	1.48	1	0	0.0	0.00	1.0e+00	ZBTB38
Whole body fat mass	1.47	12	6	13.3	-0.22	4.8e-01	FOXO1 MLXIP NAGLU PACSIN1 PHF5A RP5-1115A15.1 STMN3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Smoking status: Current	1.47	1	1	2.2	0.00	1.0e+00	PHF5A
HDL Cholesterol	1.46	4	2	4.4	-0.75	1.5e-01	CCDC116 GSDMA ORMDL3 PACSIN1
Pulse wave peak to peak time	1.46	1	1	2.2	0.00	1.0e+00	ADAM1A
Knee pain experienced in last month	1.45	1	0	0.0	0.00	1.0e+00	RP11-396B14.2
Hypertension (Self-reported)	1.44	9	4	8.9	-0.10	7.9e-01	ADAM1A CLIC4 NDUFAF1 POLI RP5-1115A15.1 SIK2 SMARCE1 SUOX ZNF652
Illnesses of father: Heart disease	1.44	1	0	0.0	0.00	1.0e+00	SIK2
Mouth/teeth dental problems: Dentures	1.43	2	0	0.0	0.00	1.0e+00	PPOX U91328.19
Chronotype (morning person)	1.42	5	0	0.0	-0.65	1.1e-01	KIAA1109 NEK6 RP5-1115A15.1 SF3B1 WDR36
Birth weight	1.41	4	1	2.2	-0.34	6.6e-01	ADAM1A NFKB1 SIK2 TRAF1
Frequency of tiredness / lethargy in last 2 weeks	1.40	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Cardiovascular Disease	1.39	9	5	11.1	0.13	7.3e-01	ADAM1A CLIC4 IRF1 NDUFAF1 RP5-1115A15.1 SIK2 SMARCE1 SUOX ZNF652
Medication for pain relief, constipation, heartburn	1.39	2	1	2.2	0.00	1.0e+00	MPHOSPH9 STAT6
Medication: Blood pressure	1.39	3	2	4.4	0.00	1.0e+00	ADAM1A SIK2 ZNF652
Arm fat mass (left)	1.39	10	8	17.8	-0.52	1.2e-01	FOXO1 MLXIP NAGLU PACSIN1 RP5-1115A15.1 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Illnesses of siblings	1.38	2	0	0.0	0.00	1.0e+00	ADAM1A TRAF3
Waist Hip Ratio (WHR)	1.37	14	7	15.6	-0.60	1.7e-02	ADAM1A CLEC16A GSAP GSDMA MED24 MLXIP MPHOSPH9 NAGLU PACSIN1 RP11-396B14.2 RP11-876N24.5 SIK2 WBP1L ZBTB38
Father's age at death	1.37	1	0	0.0	0.00	1.0e+00	SLC22A5
Arm fat mass (right)	1.37	10	7	15.6	-0.53	1.2e-01	FOXO1 MLXIP NAGLU PACSIN1 RP5-1115A15.1 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Birth weight of first child	1.37	2	1	2.2	0.00	1.0e+00	SUOX ZBTB38
Age at First Birth	1.36	1	0	0.0	0.00	1.0e+00	TRAF3
High blood pressure	1.36	7	4	8.9	0.00	9.9e-01	ADAM1A NDUFAF1 POLI RP5-1115A15.1 SIK2 SUOX ZNF652
Myopia	1.35	1	0	0.0	0.00	1.0e+00	STAT6
Impedance of leg (right)	1.34	10	5	11.1	0.39	2.7e-01	AQP5 GPR182 JAZF1 MLXIP NAGLU PACSIN1 SF3B1 SUOX TNFRSF14 ZNF652
Blood Red Count	1.33	22	13	28.9	0.04	8.7e-01	ADAM1A AHI1 BACH2 C17orf46 CLIC4 FOXO1 LINGO4 MLXIP NDFIP1 NDUFAF1 NFKB1 ORMDL3 POLI RGS14 SF3B1 SLC15A2 STMN3 SUOX TLR1 TRAF3 ZBTB38 ZNF217
Waist circumference	1.33	10	7	15.6	-0.67	3.5e-02	FOXO1 MLXIP NAGLU PACSIN1 RP11-373D23.3 SUOX TNFRSF14 TRAF3 U91328.19 ZBTB38
Medication: Paracetamol	1.33	1	1	2.2	0.00	1.0e+00	STAT6
Medication: Blood pressure	1.33	3	0	0.0	0.00	1.0e+00	NDUFAF1 SIK2 SLC22A5
Vitamin and mineral supplements	1.32	1	1	2.2	0.00	1.0e+00	STAT6
Impedance of leg (left)	1.32	12	5	11.1	0.34	2.8e-01	CCDC116 GPR182 JAZF1 LMBRD2 MLXIP NAGLU PACSIN1 S100A11 SF3B1 SUOX TNFRSF14 ZNF652
Leg fat percentage (right)	1.32	7	5	11.1	0.40	3.8e-01	MLXIP NDUFAF1 PACSIN1 RP5-1115A15.1 STMN3 TRAF3 U91328.19
Leg fat percentage (left)	1.32	8	6	13.3	0.29	4.9e-01	MLXIP MPHOSPH9 PACSIN1 RP5-1115A15.1 SMARCE1 STMN3 TRAF3 U91328.19
Diabetes diagnosed by doctor	1.29	2	0	0.0	0.00	1.0e+00	JAZF1 NAGLU
Body mass index (BMI)	1.27	8	8	17.8	-0.56	1.5e-01	MLXIP NAGLU PACSIN1 RP5-1115A15.1 SUOX TNFRSF14 TRAF3 U91328.19
Breastfed as a baby	1.27	2	0	0.0	0.00	1.0e+00	MPHOSPH9 NEK6
Medication: Allopurinol	1.27	2	1	2.2	0.00	1.0e+00	MLXIP OVOL1
Miserableness	1.27	3	0	0.0	0.00	1.0e+00	MED24 ORMDL3 RP5-1115A15.1
Trunk fat percentage	1.26	9	7	15.6	0.02	9.5e-01	MLXIP PACSIN1 PHF5A RP5-1115A15.1 SF3B1 TRAF3 U91328.19 ZBTB38 ZNF652
Qualifications: None of the above	1.26	2	2	4.4	0.00	1.0e+00	MPHOSPH9 SUOX
Heel bone mineral density (BMD) T-score, automated (right)	1.25	7	3	6.7	-0.33	4.7e-01	IQGAP1 JAZF1 NEK6 RP5-1115A15.1 U91328.19 ZBTB38 ZNF774
Ever smoked	1.25	1	0	0.0	0.00	1.0e+00	WBP1L
Seen a psychiatrist for nerves, anxiety, tension or depression	1.24	1	0	0.0	0.00	1.0e+00	U91328.19
Hair/balding pattern: Pattern 2	1.23	1	0	0.0	0.00	1.0e+00	CLIC4
Seen doctor (GP) for nerves, anxiety, tension or depression	1.23	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Medication for cholesterol, blood pressure or diabetes	1.23	3	1	2.2	0.00	1.0e+00	NDUFAF1 SIK2 ZNF652
Body fat percentage	1.23	9	5	11.1	-0.06	8.8e-01	MLXIP NAGLU PACSIN1 PHF5A RP5-1115A15.1 STMN3 TRAF3 U91328.19 ZBTB38
Comparative body size at age 10	1.23	3	1	2.2	0.00	1.0e+00	OVOL1 U91328.19 ZNF652
Alcohol intake frequency.	1.23	4	0	0.0	-0.60	4.0e-01	NAGLU NFKB1 STAT6 SUOX
Past tobacco smoking	1.22	2	1	2.2	0.00	1.0e+00	ADAM1A WBP1L
Number of live births	1.22	1	0	0.0	0.00	1.0e+00	NFKB1
Shortness of breath walking on level ground	1.22	1	0	0.0	0.00	1.0e+00	LRRC32
Bipolar Disorder or Schizophrenia	1.21	2	1	2.2	0.00	1.0e+00	SF3B1 STAT6
Schizophrenia (2018)	1.21	2	1	2.2	0.00	1.0e+00	SF3B1 STAT6
Age at first live birth	1.21	1	0	0.0	0.00	1.0e+00	SUOX
Pain experienced in last month	1.21	2	1	2.2	0.00	1.0e+00	STAT6 SUOX
Forced expiratory volume in 1-second (FEV1)	1.20	6	1	2.2	-0.64	8.8e-02	AHI1 LINGO4 PACSIN1 STMN3 SUOX ZBTB38
Heel T-Score	1.19	11	9	20.0	-0.08	8.1e-01	CCDC116 IQGAP1 JAZF1 LCLAT1 MPHOSPH9 NEK6 OVOL1 RP5-1115A15.1 SLC15A2 ZBTB38 ZNF774
Type 2 Diabetes (T2D) (2018)	1.19	2	0	0.0	0.00	1.0e+00	ADAM1A JAZF1
Diabetes (self-reported)	1.19	1	0	0.0	0.00	1.0e+00	NAGLU
Medication: Ibuprofen (e.g. Nurofen)	1.19	1	1	2.2	0.00	1.0e+00	STAT6
Forced expiratory volume in 1-second (FEV1), Best measure	1.19	4	1	2.2	-0.55	3.3e-01	LINGO4 PACSIN1 SUOX ZBTB38
Qualifications: College or University degree	1.19	3	2	4.4	0.00	1.0e+00	MPHOSPH9 STMN3 SUOX
Neck or shoulder pain in last month	1.19	3	0	0.0	0.00	1.0e+00	NEK6 RP5-1115A15.1 SUOX
Lung FVC	1.18	10	5	11.1	-0.57	5.2e-02	AHI1 FAM177A1 LINGO4 MPHOSPH9 ORMDL3 SLC22A5 SPPL3 STMN3 SUOX ZBTB38
Multivitamins +/- minerals	1.18	1	0	0.0	0.00	1.0e+00	STAT6
Tense / 'highly strung'	1.18	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Depression (Nagel 2018)	1.17	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
BMI	1.17	12	6	13.3	-0.38	2.3e-01	GSDMA MED24 MLXIP NAGLU NEK6 PACSIN1 RP5-1115A15.1 STMN3 SUOX TLR1 TNFRSF14 TRAF3
Frequency of depressed mood in last 2 weeks	1.17	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Angina	1.17	1	0	0.0	0.00	1.0e+00	ZNF652
Ever had bowel cancer screening	1.17	1	0	0.0	0.00	1.0e+00	SIK2
Schizophrenia (2014)	1.16	4	1	2.2	0.44	5.6e-01	MPHOSPH9 RP5-1115A15.1 SF3B1 STAT6
Heel bone mineral density (BMD) T-score, automated (left)	1.16	3	2	4.4	0.00	1.0e+00	IQGAP1 RP5-1115A15.1 ZNF774
Forced vital capacity (FVC)	1.16	6	3	6.7	-0.55	1.6e-01	AHI1 LINGO4 PACSIN1 STMN3 WBP1L ZBTB38
Medication: Aspirin	1.15	1	0	0.0	0.00	1.0e+00	SIK2
Ever used hormone-replacement therapy (HRT)	1.14	1	0	0.0	0.00	1.0e+00	NEK6
Depression (self-reported)	1.14	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Heart attack	1.12	1	0	0.0	0.00	1.0e+00	ZNF652
Systolic Blood Pressure	1.11	12	6	13.3	0.04	9.1e-01	ADAM1A C17orf46 CCDC116 CLIC4 MLXIP NDUFAF1 NEK6 RP11-373D23.3 RP5-1115A15.1 SIK2 SLC15A2 ZNF652
Systolic blood pressure, automated reading	1.11	4	2	4.4	0.61	3.9e-01	NDUFAF1 RP5-1115A15.1 SLC15A2 STMN3
Relative age voice broke	1.10	1	0	0.0	0.00	1.0e+00	SPPL3
Arm fat percentage (left)	1.10	8	6	13.3	-0.39	3.4e-01	MLXIP NAGLU PACSIN1 PHF5A RP5-1115A15.1 TNFRSF14 TRAF3 U91328.19
Fluid intelligence score	1.09	2	0	0.0	0.00	1.0e+00	MPHOSPH9 SUOX
Arm fat percentage (right)	1.09	9	6	13.3	-0.17	6.7e-01	MLXIP NAGLU NDUFAF1 PACSIN1 RP5-1115A15.1 SUOX TNFRSF14 TRAF3 U91328.19
Forced vital capacity (FVC), Best measure	1.09	7	1	2.2	-0.39	3.0e-01	AHI1 LINGO4 MSL1 PACSIN1 STMN3 WBP1L ZBTB38
Medication: Paracetamol	1.09	1	1	2.2	0.00	1.0e+00	STAT6
Heart attack/myocardial infarction (self-reported)	1.09	1	0	0.0	0.00	1.0e+00	ZNF652
Depressed Affect (Nagel 2018)	1.08	3	1	2.2	0.00	1.0e+00	MED24 PHF5A RP5-1115A15.1
Angina (self-reported)	1.08	1	0	0.0	0.00	1.0e+00	ZNF652
Overall health rating	1.08	3	1	2.2	0.00	1.0e+00	PACSIN1 SF3B1 ZNF652
Medication: Simvastatin	1.07	1	0	0.0	0.00	1.0e+00	NDUFAF1
Qualifications: O levels/GCSEs or equivalent	1.07	1	1	2.2	0.00	1.0e+00	MPHOSPH9
Medication: Lisinopril	1.07	1	0	0.0	0.00	1.0e+00	MLXIP
Relative age of first facial hair	1.06	3	1	2.2	0.00	1.0e+00	PIBF1 SPPL3 ZBTB38
Hair/balding pattern: Pattern 3	1.06	1	0	0.0	0.00	1.0e+00	CLIC4
Medication: Ramipril	1.05	1	0	0.0	0.00	1.0e+00	ADAM1A
Medication: Ibuprofen	1.05	1	1	2.2	0.00	1.0e+00	STAT6
Hand grip strength (left)	1.04	4	3	6.7	-0.51	4.9e-01	IRF1 SLC22A5 WBP1L ZBTB38
Loneliness, isolation	1.04	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Alzheimer’s Disease (including proxy)	1.03	1	0	0.0	0.00	1.0e+00	PPOX
Mood swings	1.03	1	0	0.0	0.00	1.0e+00	PHF5A
Hearing difficulty/problems with background noise	1.02	1	0	0.0	0.00	1.0e+00	WBP1L
Irritability	1.02	1	0	0.0	0.00	1.0e+00	MRPS33
Neuroticism (Nagel 2018)	1.01	3	0	0.0	0.00	1.0e+00	MED24 PHF5A RP5-1115A15.1
Maternal smoking around birth	1.00	1	0	0.0	0.00	1.0e+00	PHF5A
Age when periods started (menarche)	1.00	1	0	0.0	0.00	1.0e+00	SUOX
Nervous feelings	1.00	1	0	0.0	0.00	1.0e+00	U91328.19
Qualifications: A levels/AS levels or equivalent	1.00	2	1	2.2	0.00	1.0e+00	MPHOSPH9 SUOX
Pulse rate, automated reading	1.00	5	1	2.2	0.64	2.5e-01	PACSIN1 SIK2 SUOX U91328.19 ZBTB38
HbA1C	0.97	1	0	0.0	0.00	1.0e+00	ADAM1A
Qualifications: nursing, teaching	0.97	1	0	0.0	0.00	1.0e+00	MPHOSPH9
Pulse rate	0.96	1	1	2.2	0.00	1.0e+00	ZBTB38
Triglycerides	0.95	1	1	2.2	0.00	1.0e+00	RP11-373D23.3
Hand grip strength (right)	0.95	5	3	6.7	-0.63	2.5e-01	IRF1 SLC22A5 STAT6 WBP1L ZBTB38
Worry too long after embarrassment	0.94	1	0	0.0	0.00	1.0e+00	AHI1
Verbal and Numeric Reasoning (VNR)	0.91	1	0	0.0	0.00	1.0e+00	SUOX
Worry (Nagel 2018)	0.90	1	0	0.0	0.00	1.0e+00	PACSIN1
Suffer from 'nerves'	0.85	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Medication: Cholesterol lowering	0.84	1	0	0.0	0.00	1.0e+00	NDUFAF1
Neuroticism	0.79	1	0	0.0	0.00	1.0e+00	RP5-1115A15.1
Neuroticism score	0.79	2	0	0.0	0.00	1.0e+00	PHF5A RP5-1115A15.1
Intelligence (Savage-Jansen 2018)	0.76	3	0	0.0	0.00	1.0e+00	IL18RAP MPHOSPH9 SUOX
Hair Pigment	0.31	8	5	11.1	0.56	1.2e-01	JAZF1 MPHOSPH9 MSL1 RP11-373D23.3 RP5-1115A15.1 SUOX TRAF3 ZBTB38
Tanning	0.23	2	0	0.0	0.00	1.0e+00	JAZF1 RP11-373D23.3

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	5	0.98	2.6
YFS	Blood	35	0.76	2.4
The Cancer Genome Atlas	Testicular Germ Cell Tumors	14	1.09	2.4
GTEx	Brain Cortex	9	0.87	2.3
GTEx	Brain Nucleus accumbens basal ganglia	8	0.92	2.3
GTEx	Breast Mammary Tissue	16	0.81	2.3
GTEx	Breast Mammary Tissue (Female)	13	0.79	2.3
GTEx	Esophagus Mucosa	21	0.63	2.3
GTEx	Pancreas	14	0.86	2.3
GTEx	Testis	22	0.70	2.3
GTEx	Whole Blood	17	0.85	2.3
NTR	Blood	20	0.83	2.3
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	15	0.55	2.3
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	23	0.56	2.3
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	15	0.73	2.3
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	20	0.80	2.3
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	12	0.75	2.3
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	16	0.96	2.3
GTEx	Adipose Subcutaneous	21	0.60	2.2
GTEx	Adipose Visceral Omentum	13	0.64	2.2
GTEx	Brain Frontal Cortex BA9	5	0.54	2.2
GTEx	Brain Hypothalamus	4	0.68	2.2
GTEx	Brain Putamen basal ganglia	6	0.96	2.2
GTEx	Breast Mammary Tissue (Male)	8	0.67	2.2
GTEx	Cells Transformed fibroblasts	31	0.74	2.2
GTEx	Colon Sigmoid	10	0.68	2.2
GTEx	Colon Transverse	14	0.68	2.2
GTEx	Esophagus Gastroesophageal Junction	10	0.69	2.2
GTEx	Esophagus Muscularis	23	0.71	2.2
GTEx	Heart Atrial Appendage	7	0.44	2.2
GTEx	Liver	4	0.56	2.2
GTEx	Skin Not Sun Exposed Suprapubic	18	0.73	2.2
GTEx	Spleen	11	0.78	2.2
GTEx	Thyroid	32	0.80	2.2
GTEx	Uterus	5	0.88	2.2
METSIM	Adipose	26	0.56	2.2
ROSMAP	Brain Pre-frontal Cortex	24	0.55	2.2
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	10	0.60	2.2
The Cancer Genome Atlas	Breast Invasive Carcinoma	27	0.61	2.2
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	7	0.64	2.2
The Cancer Genome Atlas	Glioblastoma Multiforme	7	0.68	2.2
The Cancer Genome Atlas	Brain Lower Grade Glioma	25	0.58	2.2
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.27	2.2
The Cancer Genome Atlas	Lung Adenocarcinoma	15	0.51	2.2
The Cancer Genome Atlas	Stomach Adenocarcinoma	12	0.71	2.2
The Cancer Genome Atlas	Thyroid Carcinoma	38	0.74	2.2
GTEx	Artery Aorta	15	0.50	2.1
GTEx	Artery Coronary	5	0.42	2.1
GTEx	Artery Tibial	20	0.53	2.1
GTEx	Brain Cerebellar Hemisphere	9	0.60	2.1
GTEx	Brain Cerebellum	11	0.55	2.1
GTEx	Lung	21	0.73	2.1
GTEx	Muscle Skeletal	16	0.55	2.1
GTEx	Nerve Tibial	19	0.44	2.1
GTEx	Ovary	7	0.77	2.1
GTEx	Pituitary	9	0.81	2.1
GTEx	Prostate	5	0.60	2.1
GTEx	Skin Sun Exposed Lower leg	23	0.63	2.1
GTEx	Vagina	2	0.31	2.1
CommonMind	Brain Pre-frontal Cortex	27	0.50	2.1
The Cancer Genome Atlas	Colon Adenocarcinoma	11	0.53	2.1
The Cancer Genome Atlas	Esophageal Carcinoma	5	0.73	2.1
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	8	0.60	2.1
The Cancer Genome Atlas	Prostate Adenocarcinoma	26	0.56	2.1
GTEx	Adrenal Gland	8	0.55	2.0
GTEx	Cells EBV-transformed lymphocytes	7	0.49	2.0
GTEx	Small Intestine Terminal Ileum	3	0.65	2.0
GTEx	Stomach	7	0.48	2.0
The Cancer Genome Atlas	Rectum Adenocarcinoma	5	0.72	2.0
The Cancer Genome Atlas	Soft Tissue Sarcoma	4	0.37	2.0
The Cancer Genome Atlas	Skin Cutaneous Melanoma	5	0.93	2.0
GTEx	Brain Caudate basal ganglia	3	0.33	1.9
GTEx	Brain Hippocampus	2	0.38	1.9
GTEx	Heart Left Ventricle	5	0.33	1.9